(Q41587455)

4 October 2017

1 reference

title

Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment (English)

1 reference

antiphospholipid syndrome

4 October 2017

main subject

1 reference

Nesher G

1

1 reference

4 October 2017

Ilany J

series ordinal

2

1 reference

4 October 2017

Rosenmann D

series ordinal

3

1 reference

4 October 2017

Abraham AS

series ordinal

4

1 reference

4 October 2017

publication date

1 August 1997

1 reference

Seminars in Arthritis and Rheumatism

4 October 2017

published in

1 reference

4 October 2017

volume

27

1 reference

4 October 2017

issue

1

1 reference

4 October 2017

page(s)

27-35

1 reference

Antiphospholipid antibody syndrome: immunologic and clinical aspects

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiovascular manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiac involvement in systemic lupus erythematosus detected by echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Frequency of valvular regurgitation by color Doppler echocardiography in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Clinically significant valvular heart disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Cardiac involvement in patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Valvular heart disease in the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Non-infective verrucous endocarditis in a patient with 'primary' antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Prevalence of cardiac abnormalities early in the course of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Reversible dementia and chorea in a young woman with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Severe mitral valvular disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980034-0

7 January 2021

10.1016/S0049-0172(97)80034-0

Identifiers

DOI

1 reference

4 October 2017

1 reference